Against a fairly bleak outlook for the UK economy, Jeremy Hunt’s latest budget as UK Chancellor of the Exchequer contained a number of measures that have been well receive
Groups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK autumn budget, despite a longer timeline for reaching the target of £
Hopes that the UK government would step in to support charity-funded medical research were dashed when the sector received no mention in the Budget despite campaigns to secure additional su